Amarin Jumps Another 17%

Shares of Amarin

have surged another 17% on Friday amid takeover rumors and optimism about a U.S. patent for the company's lead drug candidate AMR-101. Yesterday, I

that a takeover could come at a large premium to current prices. Another possibility is that Amarin could strike a partnership deal with a larger pharmaceutical company. On Friday, the stock is trading at $10.49, a new multi-month high. Volume has been extremely heavy with more than 17 million AMRN shares trading hands compared to a 3-month daily average of 3.1 million.